Funded Tech Companies
Optherion
Wondering who provided funding to Optherion? Domain Associates, Quaker Partners and private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Optherion
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
555 Long Wharf Drive 11th Floor
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Company Background Information
Overview
Optherion, Inc. is an early-stage biotechnology company that is developing diagnostic and disease-modifying products for the management and treatment of dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system.Optherion's intellectual properties are based on recent scientific discoveries linking certain genes to AMD.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2009
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colin Foster
Company Investors
- Domain Associates (Brian Halak)
- Quaker Partners (Sherrill Neff)
- Biogen Idec
- Johnson & Johnson Development Corporation
- Pappas Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs